As we continue to fight against the Covid-19 pandemic, it is vital that no one is excluded from vaccine coverage. This briefing note addresses some of the challenges faced by displaced people – including refugees, asylum seekers, IDPs, stateless people, and others in displacement contexts – in accessing Covid-19 vaccinations.
Nearly 70 poor countries will only be able to vaccinate one in ten people against COVID-19 next year unless urgent action is taken by governments and the pharmaceutical industry to make sure enough doses are produced.
Responding to the announcement that COVAX has received more funding and is planning to accelerate its vaccine rollout, Oxfam International’s Head of Inequality Policy, Max Lawson, said: “More funding for COVAX and a quicker rollout of vaccines is a small piece of good news for developing countries struggling to get the doses they need, but at best fewer than a quarter of people in these countries will have been vaccinated by the end of the year."
Campaigners from the People’s Vaccine Alliance say the refusal of pharmaceutical companies to openly share their vaccine science and technology and the lack of action from rich countries to ensure access to vaccines globally have created the perfect breeding ground for new variants such as Omicron.
Rich countries have secured almost three times as many courses of a World Health Organisation (WHO)-recommended COVID-19 medicine, Pfizer’s Paxlovid, according to new analysis from Oxfam and the People’s Vaccine Alliance.
